Derma Sciences

Derma Sciences is a Medical Devices company specializing in the field of Advanced Wound Care. Currently their major products are Medihoney, Algicell AG, Xtrasorb wound dressing, Bioguard and Mobility1. Their newest product DSC127 - an Angiotensin Analog - is currently in Phase II Pre-Clinical trials.
Type
Subsidiary
Parent Company
Integra LifeSciences
HQ
Princeton, US
Founded
1984
Derma Sciences was founded in 1984 and is headquartered in Princeton, US

Key People/Management at Derma Sciences

John E. Yetter

John E. Yetter

CFO & Vice President of Finance
Srini Conjeevaram

Srini Conjeevaram

Director

Derma Sciences Office Locations

Derma Sciences has offices in Princeton and New York
Princeton, US (HQ)
300 214 Carnegie Center
New York, US
800 3rd Ave

Derma Sciences Financials and Metrics

Derma Sciences Summary

Founding Date

1984

Total Funding

$29.1 m
Derma Sciences is a subsidiary of Integra LifeSciences

Derma Sciences Financials

Derma Sciences's revenue was reported to be $84.5 m in FY, 2015
USDFY, 2013FY, 2014FY, 2015

Revenue

79.7 m83.7 m84.5 m

Revenue growth, %

5%1%

Cost of goods sold

50.3 m53.6 m51.7 m

Gross profit

29.4 m30.1 m32.7 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

Revenue

22.1 m19.8 m20.9 m20.2 m19.5 m22.6 m22.2 m20.2 m22.2 m21.8 m

Cost of goods sold

14 m12.9 m13.1 m13.8 m12 m14.2 m13.7 m12.5 m13.9 m11.1 m

Gross profit

8 m6.9 m7.8 m6.4 m7.5 m8.4 m8.4 m7.7 m8.3 m10.7 m

Gross profit Margin, %

36%35%38%32%39%37%38%38%37%49%
USDFY, 2013FY, 2014FY, 2015

Cash

6.5 m19.4 m15.8 m

Accounts Receivable

7.3 m8.8 m8.1 m

Inventories

16.5 m13.3 m20.7 m

Current Assets

49.5 m100.8 m71.1 m
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

Cash

5.4 m57.1 m57.1 m43.3 m16.5 m13 m14.4 m11.8 m19 m26 m

Accounts Receivable

8.5 m7.7 m7.9 m7.5 m

Inventories

15.1 m18.1 m17.6 m15 m15.8 m17.5 m18.3 m21.4 m18.3 m14.4 m

Current Assets

53.1 m122.3 m117.1 m110.1 m93.7 m86.3 m78.1 m67.8 m72.6 m69.3 m
USDFY, 2013FY, 2014FY, 2015

Net Income

(24 m)(39.8 m)(38.1 m)

Accounts Receivable

(266.8 k)(1.4 m)324.2 k

Inventories

(3 m)2.6 m(9.1 m)

Accounts Payable

574.3 k679.9 k(1.6 m)
USDQ3, 2013Q1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016

Net Income

(18.5 m)(10.3 m)(19 m)(30.2 m)(10.6 m)(19.9 m)(28.9 m)(1.8 m)224.8 k(1.2 m)

Accounts Receivable

(1.5 m)(360.9 k)(521.8 k)(214.6 k)448.8 k(560.8 k)(158.8 k)13.6 k(1.2 m)(335.1 k)

Inventories

(1.7 m)(2 m)(1.3 m)1 m(3 m)(4.6 m)(5.7 m)(209.3 k)2.5 m3.9 m

Accounts Payable

1.4 m1.1 m89.7 k1.4 m1.3 m1.3 m(310.4 k)(468.9 k)(912.9 k)(876.1 k)
Show all financial metrics

Derma Sciences Operating Metrics

FY, 2015

Patents (US)

50
Show all operating metrics

Derma Sciences Revenue Breakdown

Derma Sciences's Web-traffic and Trends

Derma Sciences Online and Social Media Presence

Derma Sciences Company Life and Culture

You may also be interested in